دورية أكاديمية
Indomethacin patent ductus arteriosus prophylaxis in the modern era: renal implications.
| العنوان: | Indomethacin patent ductus arteriosus prophylaxis in the modern era: renal implications. |
|---|---|
| المؤلفون: | Steflik HJ; Department of Pediatrics, Medical University of South Carolina, Charleston, SC, USA. steflikh@musc.edu., Wessler LA; College of Medicine, Medical University of South Carolina, Charleston, SC, USA., Shugart WW; College of Medicine, Medical University of South Carolina, Charleston, SC, USA., Wagner CL; Department of Pediatrics, Medical University of South Carolina, Charleston, SC, USA., Selewski DT; Department of Pediatrics, Medical University of South Carolina, Charleston, SC, USA., Twombley KE; Department of Pediatrics, Medical University of South Carolina, Charleston, SC, USA., Newman JC; Department of Medicine, Medical University of South Carolina, Charleston, SC, USA., Atz AM; Department of Pediatrics, Medical University of South Carolina, Charleston, SC, USA., Annibale DJ; Department of Pediatrics, Medical University of South Carolina, Charleston, SC, USA. |
| المصدر: | Journal of perinatology : official journal of the California Perinatal Association [J Perinatol] 2023 Aug; Vol. 43 (8), pp. 1045-1046. Date of Electronic Publication: 2023 Apr 21. |
| نوع المنشور: | Journal Article; Research Support, Non-U.S. Gov't |
| اللغة: | English |
| بيانات الدورية: | Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 8501884 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5543 (Electronic) Linking ISSN: 07438346 NLM ISO Abbreviation: J Perinatol Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: 2001- : New York, NY : Nature Publishing Group Original Publication: [Philadelphia, Pa. : W.B. Saunders, c1984- |
| مواضيع طبية MeSH: | Ductus Arteriosus, Patent*/drug therapy , Ductus Arteriosus, Patent*/prevention & control , Persistent Fetal Circulation Syndrome*/drug therapy , Ductus Arteriosus*, Infant, Newborn ; Humans ; Indomethacin/therapeutic use ; Infant, Premature ; Kidney |
| References: | Fowlie PW, Davis PG, McGuire W. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev. 2010;2010:CD000174. Raknoo T, Janjindamai W, Sitaruno S, Dissaneevate S, Ratanajamit C. Incidence, risk and risk factors for acute kidney injury associated with the use of intravenous indomethacin in neonatal patent ductus arteriosus: A 16-year retrospective cohort study. Pharm Pract (Granada). 2021;19:2409. (PMID: 35474648) Group. KDIGOKAKIW. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney International Supplement. 2012;2:1–138. Guillet R, Selewski DT, Griffin R, Rastogi S, Askenazi DJ, D’Angio CT. Relationship of patent ductus arteriosus management with neonatal AKI. J Perinatol. 2021;41:1441–7. (PMID: 10.1038/s41372-021-01054-1338757958238821) |
| المشرفين على المادة: | XXE1CET956 (Indomethacin) |
| تواريخ الأحداث: | Date Created: 20230421 Date Completed: 20230807 Latest Revision: 20230810 |
| رمز التحديث: | 20240628 |
| DOI: | 10.1038/s41372-023-01681-w |
| PMID: | 37085522 |
| قاعدة البيانات: | MEDLINE |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 1476-5543 |
|---|---|
| DOI: | 10.1038/s41372-023-01681-w |